Imaging has emerged as one of the key tools used by biomedical investigators to further our understanding of human biology in health and disease. XNAT has emerged as the most widely used imaging informatics for supporting this research. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on four key use cases: institutional repositories, clinical imaging research, multi-center trials, and data sharing. A variety of new capabilities wil be implemented, including deeper integration with clinical information systems, scalability services including integration with the cloud, on- demand access to statistical and other computational platforms, a GUI-based form building interface, configurable data feeds, and quality assurance and communications tools. These capabilities will be developed and evaluated in the context of real world scientific programs. A number of outreach and support activities targeted at XNAT users and developers.
Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.
|Gurney, Jenny; Olsen, Timothy; Flavin, John et al. (2017) The Washington University Central Neuroimaging Data Archive. Neuroimage 144:287-293|
|Mishra, Shruti; Gordon, Brian A; Su, Yi et al. (2017) AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. Neuroimage 161:171-178|
|Dierker, Donna; Roland, Jarod L; Kamran, Mudassar et al. (2017) Resting-state Functional Magnetic Resonance Imaging in Presurgical Functional Mapping: Sensorimotor Localization. Neuroimaging Clin N Am 27:621-633|
|Goyal, Manu S; Vlassenko, Andrei G; Blazey, Tyler M et al. (2017) Loss of Brain Aerobic Glycolysis in Normal Human Aging. Cell Metab 26:353-360.e3|
|Natelson Love, Marissa; Clark, David G; Cochran, J Nicholas et al. (2017) Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease. Neurobiol Aging 49:216.e7-216.e13|
|Babulal, Ganesh M; Ghoshal, Nupur; Head, Denise et al. (2016) Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Am J Geriatr Psychiatry 24:1095-1104|
|Kogan, Alex; Alpert, Kathryn; Ambite, Jose Luis et al. (2016) Northwestern University schizophrenia data sharing for SchizConnect: A longitudinal dataset for large-scale integration. Neuroimage 124:1196-201|
|Brier, Matthew R; McCarthy, John E; Benzinger, Tammie L S et al. (2016) Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease. Neurobiol Aging 38:104-111|
|Glasser, Matthew F; Smith, Stephen M; Marcus, Daniel S et al. (2016) The Human Connectome Project's neuroimaging approach. Nat Neurosci 19:1175-87|
|Lee, Megan H; Miller-Thomas, Michelle M; Benzinger, Tammie L et al. (2016) Clinical Resting-state fMRI in the Preoperative Setting: Are We Ready for Prime Time? Top Magn Reson Imaging 25:11-8|
Showing the most recent 10 out of 28 publications